Pulmonary Mucormycosis (Zygomycosis) in a Lung Transplant Recipient: Recovery after Posaconazole Therapy
Olivier Brugi re(Hôpital Necker-Enfants Malades), B. Dupont(Délégation Paris 5), Herv Mal(Hôpital Necker-Enfants Malades), Ga lle Dauriat(Hôpital Necker-Enfants Malades), Michel Fournier(The Lymphoma Academic Research Organisation), O Groussard(Hôpital Necker-Enfants Malades), Mathieu Besnard(Hôpital Necker-Enfants Malades), Rolana Marrash-Chalha(Hôpital Necker-Enfants Malades)
Cited by 48
Related Papers
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007
|Clinical Microbiology and Infection|2011|752
Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections
|Clinical Infectious Diseases|2003|680
Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria
|Clinical Infectious Diseases|2008|469
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children
|The Pediatric Infectious Disease Journal|2002|436